Advertisement

Topics

BrainScope Company Inc. Company Profile

03:32 EDT 19th June 2019 | BioPortfolio

BrainScope is a medical neurotechnology company that is developing a new generation of handheld, easy-to-use, non-invasive instruments designed to aid medical professionals in rapidly and objectively assessing various neurological conditions, starting with traumatic brain injury including concussion. The company has completed 20 clinical studies at 55 locations, with its technology featured in 15 peer-reviewed articles in leading scientific and medical publications. The Company has received nearly $30 million of Department of Defense contracts and other grants to conduct its scientific research. It is backed by Revolution (created by AOL co-founder Steve Case), Shaman Ventures, ZG Ventures, State of Maryland Venture Fund, Brain Trust Accelerator Fund, and Difference Capital. BrainScope devices in development are based on a proprietary technology platform, which integrates databases of over 6,000 brainwave recordings with advanced digital signal processing, sophisticated algorithms, miniaturized hardware and disposable headset sensors. The Company holds over 100 issued and pending patents on its technology. In May 2015 the United States Food and Drug Administration (FDA) cleared the company’s Ahead 200 device, which uses commercial smartphone hardware leveraging Google’s Android operating system and a custom sensor to record and analyze a patient’s electroencephalogram (EEG) after head injury. BrainScope devices under development, including the Ahead 300 and the Ahead Concussion Assessment System, for assessment of traumatically-induced structural head injury and concussion are for investigational use only. For more information, please visit www.brainscope.com.


News Articles [126 Associated News Articles listed on BioPortfolio]

BrainScope concussion Dx device cleared for new indication language

The FDA has granted BrainScope clearance to market its BrainScope One concussion assessment device to determine the likeliho -More- 

BrainScope completes mTBI device validation study

A validation study of the BrainScope One multimodal head injury assessment device has been completed by BrainScope.  -More- 

FDA approves BrainScope’s multi-modal concussion assessment

BrainScope stated that the clearance will let the company to add key terminology related to ‘multi-modal, multi-parameter assessment’ of ‘concussion’ and ‘mild Traumatic Brain Injury’, as ...

BrainScope gets US FDA clearance for multi─modal, multi─parameter concussion assessment

BrainScope, a medical neuro─technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, has received FDA clearance to include additional language in its product's Ind...

Ron Klain Joins BrainScope Board of Directors

Brings Extensive Experience in Industry, Government and Public Health BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (m...

BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment

New Concussion-Specific FDA Labeling Adds to Existing BrainScope Claims Complements Multi-Modal Technology Platform and Extensive Intellectual Property Portfolio T...

BrainScope Announces Publication Describing Proprietary Concussion Biomarker to Assess Potential Severity and Predict Prolonged Recovery

Future Capability Could Aid in Objective Return-to-Activity Decisions BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (m...

BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics

Culmination of Four-Year Project With U.S. Department of Defense and NFL-GE Research Funding BrainScope®, a medical neuro-technology company focused on concussion and ...

Clinical Trials [88 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes

This study is designed to validate the performance of the algorithms to be used in future commercial device.

Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation and Treatment Optimization

This study is designed to collect data which will be used to correlate changes in EEG to mild TBI in sports concussion.

Validation of Brain Function Assessment Algorithm for mTBI From Initial Injury to Rehabilitation

This study is a validation of prior algorithms applied to the 13-25 year old population.

Companies [1490 Associated Companies listed on BioPortfolio]

BrainScope® Company, Inc.

Backed by Revolution LLC (created by AOL co-founder Steve Case), Alafi Capital, Brain Trust Accelerator Fund, Draper Fisher Jurvetson, Portage Ventures and ZG Ventures, BrainScope...

BrainScope Company, Inc.

Backed by Revolution LLC (created by AOL co-founder Steve Case), Alafi Capital, Brain Trust Accelerator Fund, Draper Fisher Jurvetson, Portage Ventures and ZG Ventures, BrainScope is a medical neurote...

BrainScope Company, Inc

BrainScope Company, Inc is a privately held medical neurotechnology company developing a new generation of portable, simple-to-use, non-invasive instruments to rapidly, and objectively assess brain fu...

BrainScope Company Inc.

BrainScope is a medical neurotechnology company that is developing a new generation of handheld, easy-to-use, non-invasive instruments designed to aid medical professionals in rap...

The St. Joe Company

The St. Joe Company, together with its consolidated subsidiaries, is a real estate developer and manager. The Company owns land concentrated primarily in Northwest Florida and has...

More Information about "BrainScope Company Inc." on BioPortfolio

We have published hundreds of BrainScope Company Inc. news stories on BioPortfolio along with dozens of BrainScope Company Inc. Clinical Trials and PubMed Articles about BrainScope Company Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BrainScope Company Inc. Companies in our database. You can also find out about relevant BrainScope Company Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...


Corporate Database Quicklinks



Searches Linking to this Company Record